Arcus Biosciences (RCUS) Treasury Shares (2017 - 2018)

Arcus Biosciences' Treasury Shares history runs 9 years deep, the most recent figure standing at $2.9 million for Q4 2025.

• In Q4 2025, Treasury Shares rose 31.82% year-over-year to $2.9 million; the TTM figure through Dec 2025 stood at $2.9 million (up 31.82% YoY), while the FY2025 annual figure was $2.9 million, up 31.82% from the prior year.
• Treasury Shares for Q4 2025 stood at $2.9 million, up from $2.2 million in the prior quarter.
• The five-year high for Treasury Shares was $2.9 million in Q4 2025, with the low at $1.1 million in Q4 2021.
• The 5-year median for Treasury Shares is $1.5 million (2023), against an average of $1.8 million.
• The sharpest annual moves came in 2021 and 2023: Treasury Shares soared 566.13% in 2021, then gained 15.38% in 2023.
• Arcus Biosciences' Treasury Shares stood at $1.1 million in 2021, then grew by 18.18% to $1.3 million in 2022, then rose by 15.38% to $1.5 million in 2023, then jumped by 46.67% to $2.2 million in 2024, then soared by 31.82% to $2.9 million in 2025.
• Business Quant data shows RCUS's Treasury Shares at $2.9 million in Q4 2025, $2.2 million in Q4 2024, and $1.5 million in Q4 2023.